tiprankstipranks
Trending News
More News >
Steris (STE)
:STE
US Market
Advertisement

Steris (STE) Earnings Dates, Call Summary & Reports

Compare
427 Followers

Earnings Data

Report Date
Feb 11, 2026
After Close (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
2.53
Last Year’s EPS
2.32
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with significant growth in revenue, margins, and earnings per share. While there are concerns about tariffs, inflation, and tax rates, the positive growth in various segments and the increased outlook for fiscal 2026 contribute to a generally optimistic sentiment.
Company Guidance
During the STERIS plc 2Q Fiscal 2026 earnings call, several key metrics were highlighted, showcasing the company's robust financial performance and updated guidance. Total as-reported revenue grew by 10%, with constant currency organic revenue increasing by 9%, driven by a 210 basis point price increase. The gross margin rose by 60 basis points to 44.3%, while the EBIT margin improved by 90 basis points to 23.1% of revenue. The adjusted effective tax rate was 24.5%, and net income from continuing operations reached $244.5 million. Adjusted earnings per diluted share rose by 15% year-over-year to $2.47. Capital expenditures for the first half of fiscal 2026 totaled $180.1 million, and depreciation and amortization amounted to $241.1 million. The company ended the quarter with $1.9 billion in total debt and a gross to EBITDA ratio of approximately 1.2x. Free cash flow for the first half was $527.7 million. For the fiscal year 2026 outlook, STERIS anticipates 8% to 9% as-reported revenue growth and has increased its earnings outlook to a range of $10.15 to $10.30 per share. Free cash flow guidance was raised by $30 million to $850 million, with capital expenditures remaining around $375 million.
Strong Revenue Growth
Total as-reported revenue grew 10% year-over-year with a 9% increase in constant currency organic revenue, driven by volume and pricing improvements.
Improved Gross and EBIT Margins
Gross margin increased 60 basis points to 44.3%, and EBIT margin improved by 90 basis points to 23.1%, driven by positive pricing, productivity, and operating expense leverage.
Significant Growth in Earnings Per Share
Adjusted earnings per diluted share from continuing operations were $2.47, representing a 15% increase over the prior year.
Strong Performance in AST Services
AST segment saw a 7% growth in constant currency organic revenue with 13% growth in services, driven by stable medical device volumes and bioprocessing demand.
Healthcare Segment Success
Healthcare saw 9% growth in constant currency organic revenue, with service growing 13% and consumables by 10%. EBIT margins increased by 100 basis points.
Positive Outlook for Fiscal 2026
The outlook for fiscal 2026 has been increased, with expectations of 8% to 9% as-reported revenue growth and a free cash flow outlook raised by $30 million to $850 million.

Steris (STE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

STE Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 11, 2026
2026 (Q3)
2.53 / -
2.32
Nov 05, 2025
2026 (Q2)
2.35 / 2.47
2.1415.42% (+0.33)
Aug 06, 2025
2026 (Q1)
2.26 / 2.34
2.149.35% (+0.20)
May 14, 2025
2025 (Q4)
2.60 / 2.74
2.4113.69% (+0.33)
Feb 05, 2025
2025 (Q3)
2.32 / 2.32
2.224.50% (+0.10)
Nov 06, 2024
2025 (Q2)
2.12 / 2.14
2.035.42% (+0.11)
Aug 06, 2024
2025 (Q1)
1.98 / 2.14
27.00% (+0.14)
May 08, 2024
2024 (Q4)
2.35 / 2.41
2.34.78% (+0.11)
Feb 07, 2024
2024 (Q3)
2.17 / 2.22
2.029.90% (+0.20)
Nov 07, 2023
2024 (Q2)
2.00 / 2.03
1.992.01% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

STE Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$242.58$259.42+6.94%
Aug 06, 2025
$220.09$235.05+6.80%
May 14, 2025
$225.82$245.06+8.52%
Feb 05, 2025
$218.64$223.20+2.09%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Steris (STE) report earnings?
Steris (STE) is schdueled to report earning on Feb 11, 2026, After Close (Confirmed).
    What is Steris (STE) earnings time?
    Steris (STE) earnings time is at Feb 11, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is STE EPS forecast?
          STE EPS forecast for the fiscal quarter 2026 (Q3) is 2.53.

            Steris (STE) Earnings News

            Steris (NYSE:STE): JMP Securities Analyst Bullish Following Mixed Q2 Results
            Premium
            Market Movers
            Steris (NYSE:STE): JMP Securities Analyst Bullish Following Mixed Q2 Results
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis